Dynamics of humoral immunity during natural SARS-CoV-2 infection and/or after vaccination with the ‘Sputnik V’ vaccine

Comprehensive analysis of adaptive immune response to SARS-CoV-2 is critical for epidemiological monitoring, as well as for tracking immune response stages and vaccination strategies. Understanding the differences between immunity formed after COVID-19 infection and vaccine-induced immunity is a spe...

Full description

Bibliographic Details
Main Authors: A. V. Ivanov, M. A. Uvarova, K. B. Frolov, E. V. Semenova
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2024-11-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/2919
_version_ 1826534011407695872
author A. V. Ivanov
M. A. Uvarova
K. B. Frolov
E. V. Semenova
author_facet A. V. Ivanov
M. A. Uvarova
K. B. Frolov
E. V. Semenova
author_sort A. V. Ivanov
collection DOAJ
description Comprehensive analysis of adaptive immune response to SARS-CoV-2 is critical for epidemiological monitoring, as well as for tracking immune response stages and vaccination strategies. Understanding the differences between immunity formed after COVID-19 infection and vaccine-induced immunity is a specific task within this problem. Moreover, the obvious task is to assess the effect of repeated antigenic stimulation on immunological defense against SARS-CoV-2. The aim of present study was a comparative analysis of humoral immunity (anti-SARS-CoV-2 IgA and IgG) developing after natural infection with SARS-CoV-2 and/or after vaccination with anti-COVID vaccine “Sputnik V”. The study involved 36 volunteers. 21 of them had COVID-19 and were vaccinated 8-10 months later (group 1). In 15 primarily vaccinated persons, previous SARS-CoV-2 infection was excluded by means of regular PCR screening and serological testing (group 2). Results: Intensity of humoral immune response to the primary natural SARS-CoV-2 infection and similar indexes of antiviral adaptive immunity after vaccination with “Sputnik V” vaccine were similar in both groups. However, both maximal values of anti-SARS-CoV-2 IgA and IgG and the rates of post-vaccination humoral immune response differed significantly between the persons who have previously had COVID-19 and those who have not previously been infected with SARS-CoV-2. We’ve got statistically significant differences between two groups of participants using Student’s t test comparing the average maximum IgA levels after vaccination (p < 0.05). For IgG levels, these differences are less pronounced. In the first group, the average maximal values of specific IgA and IgG levels after natural infection with SARS-CoV-2 and after subsequent vaccination differed by more than 2 times. The time intervals for reaching maximal antibody levels after vaccination proved to be significantly shorter in the subjects who had a story of COVID-19, than in persons who did not report a clinical COVID-19 infection. Concerning the terms of arising IgG antibody response after vaccination versus cases of COVID-19 in the first group, we obtained a statistically significant difference by the Student’s t-test (p < 0.05). Hence, the persons with a previous natural COVID-19 infection develop a faster, stronger and more durable response to the “Sputnik V” vaccine than the subjects who had no such infection in their history
first_indexed 2024-04-24T06:48:51Z
format Article
id doaj.art-695960fd8d6842b997dfb5312380895b
institution Directory Open Access Journal
issn 1563-0625
2313-741X
language Russian
last_indexed 2025-03-14T02:16:14Z
publishDate 2024-11-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj.art-695960fd8d6842b997dfb5312380895b2025-03-11T17:59:16ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2024-11-012661291130010.15789/1563-0625-DOH-29191863Dynamics of humoral immunity during natural SARS-CoV-2 infection and/or after vaccination with the ‘Sputnik V’ vaccineA. V. Ivanov0M. A. Uvarova1K. B. Frolov2E. V. Semenova3North-West Centre for Evidence-Based Medicine; N. Pirogov Clinic of Advanced Medical Technologies, St. Petersburg State University; St. Petersburg State Pediatric Medical UniversityNorth-West Centre for Evidence-Based MedicineSt. Petersburg State Pediatric Medical UniversityB. Konstantinov Institute of Nuclear Physics, NRC Kurchatov InstituteComprehensive analysis of adaptive immune response to SARS-CoV-2 is critical for epidemiological monitoring, as well as for tracking immune response stages and vaccination strategies. Understanding the differences between immunity formed after COVID-19 infection and vaccine-induced immunity is a specific task within this problem. Moreover, the obvious task is to assess the effect of repeated antigenic stimulation on immunological defense against SARS-CoV-2. The aim of present study was a comparative analysis of humoral immunity (anti-SARS-CoV-2 IgA and IgG) developing after natural infection with SARS-CoV-2 and/or after vaccination with anti-COVID vaccine “Sputnik V”. The study involved 36 volunteers. 21 of them had COVID-19 and were vaccinated 8-10 months later (group 1). In 15 primarily vaccinated persons, previous SARS-CoV-2 infection was excluded by means of regular PCR screening and serological testing (group 2). Results: Intensity of humoral immune response to the primary natural SARS-CoV-2 infection and similar indexes of antiviral adaptive immunity after vaccination with “Sputnik V” vaccine were similar in both groups. However, both maximal values of anti-SARS-CoV-2 IgA and IgG and the rates of post-vaccination humoral immune response differed significantly between the persons who have previously had COVID-19 and those who have not previously been infected with SARS-CoV-2. We’ve got statistically significant differences between two groups of participants using Student’s t test comparing the average maximum IgA levels after vaccination (p < 0.05). For IgG levels, these differences are less pronounced. In the first group, the average maximal values of specific IgA and IgG levels after natural infection with SARS-CoV-2 and after subsequent vaccination differed by more than 2 times. The time intervals for reaching maximal antibody levels after vaccination proved to be significantly shorter in the subjects who had a story of COVID-19, than in persons who did not report a clinical COVID-19 infection. Concerning the terms of arising IgG antibody response after vaccination versus cases of COVID-19 in the first group, we obtained a statistically significant difference by the Student’s t-test (p < 0.05). Hence, the persons with a previous natural COVID-19 infection develop a faster, stronger and more durable response to the “Sputnik V” vaccine than the subjects who had no such infection in their historyhttps://www.mimmun.ru/mimmun/article/view/2919sars-cov-2infectionvaccinesputnik vhumoral immunity
spellingShingle A. V. Ivanov
M. A. Uvarova
K. B. Frolov
E. V. Semenova
Dynamics of humoral immunity during natural SARS-CoV-2 infection and/or after vaccination with the ‘Sputnik V’ vaccine
Медицинская иммунология
sars-cov-2
infection
vaccine
sputnik v
humoral immunity
title Dynamics of humoral immunity during natural SARS-CoV-2 infection and/or after vaccination with the ‘Sputnik V’ vaccine
title_full Dynamics of humoral immunity during natural SARS-CoV-2 infection and/or after vaccination with the ‘Sputnik V’ vaccine
title_fullStr Dynamics of humoral immunity during natural SARS-CoV-2 infection and/or after vaccination with the ‘Sputnik V’ vaccine
title_full_unstemmed Dynamics of humoral immunity during natural SARS-CoV-2 infection and/or after vaccination with the ‘Sputnik V’ vaccine
title_short Dynamics of humoral immunity during natural SARS-CoV-2 infection and/or after vaccination with the ‘Sputnik V’ vaccine
title_sort dynamics of humoral immunity during natural sars cov 2 infection and or after vaccination with the sputnik v vaccine
topic sars-cov-2
infection
vaccine
sputnik v
humoral immunity
url https://www.mimmun.ru/mimmun/article/view/2919
work_keys_str_mv AT avivanov dynamicsofhumoralimmunityduringnaturalsarscov2infectionandoraftervaccinationwiththesputnikvvaccine
AT mauvarova dynamicsofhumoralimmunityduringnaturalsarscov2infectionandoraftervaccinationwiththesputnikvvaccine
AT kbfrolov dynamicsofhumoralimmunityduringnaturalsarscov2infectionandoraftervaccinationwiththesputnikvvaccine
AT evsemenova dynamicsofhumoralimmunityduringnaturalsarscov2infectionandoraftervaccinationwiththesputnikvvaccine